The philosophy of treatment of uveitis: Past, present and future

Developments in Ophthalmology

Volumn 51, Issue , 2012, Pages 1-6

  Kruh, Jonathan ^a   Foster, C Stephen ^a  

^a MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; HUMAN; TREATMENT OUTCOME; UVEITIS;

GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TREATMENT OUTCOME; UVEITIS;

EID: 84860850970     PISSN: 02503751     EISSN: 16622790     Source Type: Book Series    
DOI: 10.1159/000336183     Document Type: Article

References (28)

1. Breasted J: The Edwin Smith Surgical Papyrus. Chicago, University of Chicago Press, 1930.
2. Ebbell B: Die altagyptische Chirurgie. Die chirurgischen Abschnitte des Papyrus E. Smith and Papyrus Ebers. Oslo, Dybwad, 1939.
3. Hirschberg J: The History of Ophthalmology, vol 1 Antiquity. Bonn, Wayenborgh, 1982.
4. MacKenzie W: A Practical Treatise on the Diseases of the Eye. London, Longman, Rees, Orme, Brown & Green, 1830, pp 422-457.
5. Gordon D: Prednisone and prednisolone in ocular inflammatory disease. Am J Ophthalmol 1956;41: 593-600.
6. Fujikawa L, Meisler D, Novik R: Hyperosmolar hyperglycemic nonkeotic coma. A complication of short-term systemic corticosteroids. Ophthalmology 1983;90:1239-1242. (Pubitemid 13022176)
7. Wakakura M, Ishikawa S: Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 1984;68:329-331. (Pubitemid 15118321)
8. Polito C, La Manna A, Papale MR: Delayed pubertal growth spurt and normal adult height attainment in boys receiving long-term alternate day prednisone therapy. Clin Pediatr 1999;38:279-285. (Pubitemid 29230921)
9. American College of Rheumatology Task Force on Osteoporosis Guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 1996;39:1791-1801.
10. Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, Zink A, Buttgereit F: Doserelated patterns of glucocorticoid-induced side effects. Ann Rheum Dis 2009;68:1119-1124.
11. Nussenblatt R, Whitcup S: Uveitis Fundamentals and Clinical Practice. St Louis, Mosby, 2010, pp 81-84.
12. Pfefferman R, Gombos GM, Kountz SL: Ocular complications after renal transplantation. Ann Ophthalmol 1977;9:467-470.
13. Krumbhaar EB, Krumbhaar HD: The blood and bone marrow in yellow cross gas (mustard gas) poisoning: changes produced in the bone marrow of fatal cases. J Med Res 1919;40:497-507.
14. Gery I, Nussenblatt RB: Immunosuppressive Drugs; in Sears ML (ed.): Pharmacology of the Eye. Berlin, Springer, 1984, pp 586-609.
15. Roda-Perez E: Sobre un case se uveitis de etiologia ignota tratado con mostaza introgenada. Rev Clin Esp 1951;40:265-267.
16. Roda-Perez E: El tratamiento de las uveitis de etiologia ignota con mostaza nitrogenada. Arch Soc Ofial Hisp Am 1952;12:131-151.
17. Mamo JG, Azzam SA: Treatment of Behcet's disease with chlorambucil. Arch Ophthalmol 1970;84: 446-450.
18. Farber S, Diamond LK, Mercer RD: Temporary remissions in acute leukemia in children produced by folic antagonist 4-amethopteroylglutamic acid (aminopterin). N Engl J Med 1948;238:787-793.
19. Wong VG, Hersh EM: Methotrexate in the therapy of cyclitis. Trans Am Acad Ophthalmol Otolaryngol 1965;69:279-293.
20. Rapini RP, Jordan RE, Wolverton SE: Cytotoxic agents; in Wolverton SE, Wilkins JK (eds): Systemic Drugs for Skin Diseases. Philadelphia, WB Saunders, 1991, pp 125-151.
21. Newell FW, Krill AE: Treatment of uveitis with azathioprine (Imuran). Trans Ophthalmol Soc UK 1967;87:499-511.
22. Newell FW, Krill AE, Thompson A: The treatment of uveitis with six-mercaptopurine. Am J Ophthalmol 1966;61:1250-1255.
23. Borel JF: The history of cyclosporine A and its significance; in White DJG (ed.): Cyclosporin A. New York, Elsevier Biomedical Press, 1982, pp 5-17.
24. Nussenblatt RB, Palestine AG, Rook AH: Treatment of intraocular inflammation with Cyclosporine A. Lancet 1983;1:235-238.
25. Nussenblatt RB, Palestine AG, Chan CC: Cyclosporine A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol 1983;96:275-282. (Pubitemid 13000969)
26. Kino T, Hatanaka H, Hashimoto M: FK-506, a novel immunosuppressant isolated from Streptomyces. I. Fermentation isolation. Physico-chemical and biological characteristics. J Antibiot 1987;40: 1249-1255. (Pubitemid 17138109)
27. Sehgal S, Baker H, Vezina C: Rapamycin (AY-22, 989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J Antibiot 1975;28: 727-732.
28. Ortho Multicenter Transplant Study Group: A randomized clinical trial of OKT monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 1985;313:337-342.